1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Metabolism Drugs Market, By Therapy Type
5.1 Introduction
5.2 Substrate Reduction Therapy
5.3 Enzyme Replacement Therapy
5.4 Small Molecule Drugs
5.5 Other Therapy Types
6 Global Metabolism Drugs Market, By Drug Class
6.1 Introduction
6.2 Antihyperlipidemic Drugs
6.3 Antidiabetic Drugs
6.4 Other Drug Classes
7 Global Metabolism Drugs Market, By Distribution Channel
7.1 Introduction
7.2 Hospital Pharmacies
7.3 Retail Pharmacies
7.4 Online Pharmacies
8 Global Metabolism Drugs Market, By Application
8.1 Introduction
8.2 Diabetes Management
8.3 Obesity Treatment
8.3.1 Prescription Medications
8.3.2 OTC (Over-the-Counter) Supplements
8.4 Hyperlipidemia Management
8.4.1 Statins
8.4.2 Fibrates
8.4.3 PCSK9 Inhibitors
8.5 Thyroid Disorders
8.5.1 Hypothyroidism
8.5.2 Hyperthyroidism
8.6 Metabolic Syndrome
8.6.1 Hypertension
8.6.2 Dyslipidemia
8.6.3 Insulin Resistance
8.8 Rare Metabolic Disorders
8.8.1 Phenylketonuria (PKU)
8.8.2 Gaucher Disease
8.8.3 Fabry Disease
8.8 Other Applications
9 Global Metabolism Drugs Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Novartis AG
11.2 Merck & Co Inc.
11.3 Sanofi Genzyme
11.4 Amicus Therapeutics
11.5 AstraZeneca PLC
11.6 Horizon Pharma PLC
11.7 Shire PLC
11.8 Boehringer Ingelheim
11.9 BioMarin Pharmaceutical Inc.
11.10 Takeda Pharmaceuticals
11.11 GlaxoSmithKline PLC
11.12 Fuji Yakuhin
11.13 Mitsubishi Tanabe Pharma
11.14 Kowa Company
11.15 LG Life Science
11.16 Kythera Labs
List of Tables
Table 1 Global Metabolism Drugs Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Metabolism Drugs Market Outlook, By Therapy Type (2021-2030) ($MN)
Table 3 Global Metabolism Drugs Market Outlook, By Substrate Reduction Therapy (2021-2030) ($MN)
Table 4 Global Metabolism Drugs Market Outlook, By Enzyme Replacement Therapy (2021-2030) ($MN)
Table 5 Global Metabolism Drugs Market Outlook, By Small Molecule Drugs (2021-2030) ($MN)
Table 6 Global Metabolism Drugs Market Outlook, By Other Therapy Types (2021-2030) ($MN)
Table 7 Global Metabolism Drugs Market Outlook, By Drug Class (2021-2030) ($MN)
Table 8 Global Metabolism Drugs Market Outlook, By Antihyperlipidemic Drugs (2021-2030) ($MN)
Table 9 Global Metabolism Drugs Market Outlook, By Antidiabetic Drugs (2021-2030) ($MN)
Table 10 Global Metabolism Drugs Market Outlook, By Other Drug Classes (2021-2030) ($MN)
Table 11 Global Metabolism Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 12 Global Metabolism Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 13 Global Metabolism Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 14 Global Metabolism Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 15 Global Metabolism Drugs Market Outlook, By Application (2021-2030) ($MN)
Table 16 Global Metabolism Drugs Market Outlook, By Diabetes Management (2021-2030) ($MN)
Table 17 Global Metabolism Drugs Market Outlook, By Obesity Treatment (2021-2030) ($MN)
Table 18 Global Metabolism Drugs Market Outlook, By Prescription Medications (2021-2030) ($MN)
Table 19 Global Metabolism Drugs Market Outlook, By OTC (Over-the-Counter) Supplements (2021-2030) ($MN)
Table 20 Global Metabolism Drugs Market Outlook, By Hyperlipidemia Management (2021-2030) ($MN)
Table 21 Global Metabolism Drugs Market Outlook, By Statins (2021-2030) ($MN)
Table 22 Global Metabolism Drugs Market Outlook, By Fibrates (2021-2030) ($MN)
Table 23 Global Metabolism Drugs Market Outlook, By PCSK9 Inhibitors (2021-2030) ($MN)
Table 24 Global Metabolism Drugs Market Outlook, By Thyroid Disorders (2021-2030) ($MN)
Table 25 Global Metabolism Drugs Market Outlook, By Hypothyroidism (2021-2030) ($MN)
Table 26 Global Metabolism Drugs Market Outlook, By Hyperthyroidism (2021-2030) ($MN)
Table 27 Global Metabolism Drugs Market Outlook, By Metabolic Syndrome (2021-2030) ($MN)
Table 28 Global Metabolism Drugs Market Outlook, By Hypertension (2021-2030) ($MN)
Table 29 Global Metabolism Drugs Market Outlook, By Dyslipidemia (2021-2030) ($MN)
Table 30 Global Metabolism Drugs Market Outlook, By Insulin Resistance (2021-2030) ($MN)
Table 31 Global Metabolism Drugs Market Outlook, By Rare Metabolic Disorders (2021-2030) ($MN)
Table 32 Global Metabolism Drugs Market Outlook, By Phenylketonuria (PKU) (2021-2030) ($MN)
Table 33 Global Metabolism Drugs Market Outlook, By Gaucher Disease (2021-2030) ($MN)
Table 34 Global Metabolism Drugs Market Outlook, By Fabry Disease (2021-2030) ($MN)
Table 35 Global Metabolism Drugs Market Outlook, By Other Applications (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
